Cognoa Makes Push to Get FDA Nod for Digital Autism Diagnostic

Cognoa is vying for FDA clearance of a digital device that has the potential to diagnose autism. Previously, the Palo Alto, CA-based company was granted breakthrough device designation by FDA in 2018.